Individual is known to have one or more of the following comorbid medical conditions that prohibits the use of a HSAT: o Significant Chronic Pulmonary Disease as defined by a forced expiratory volume (FEV1)% predicted of < 60 (Pellegrino et al., 2005) o Progressive neuromuscular disease/neurodegenerative disorder (examples include but are not limited to Parkinson's disease, myotonic dystrophy,肌肌营养性的侧面硬化症,多发性硬化症患有相关肺部疾病以及持续性神经后遗症的中风病史)o中度至严重的心力衰竭[纽约心脏协会III或IV类(NYHA,1994)]或左心室射血分数≤40(Yancy等,2013; Yancy et ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex ex and> b。 2007; Blackstone andCortés,2010年)o肥胖症不足综合征o在存在睡眠障碍的存在下,持续的癫痫发作o慢性药物使用(> 3个月)(Dowell等人,2022年)也请参阅下面的重复测试部分。在适当的临床评估之后,由于排除了OSA,在适当的临床评估之后,在医学上进行了全渠道多聚会学是必要的,OSA已得到充分治疗,或者有记录的症状表明以下条件之一: